Opportunity Information: Apply for PAR 25 152

The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), is soliciting applications under the grant opportunity "Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional)," Funding Opportunity Number PAR-25-152. This is a discretionary grant program in the health and education-related federal assistance area (CFDA 93.396) that supports research examining how climate change is shaping cancer risks, prevention, detection, treatment, survivorship, and broader cancer-related outcomes across populations and places. The R21 mechanism is designed for exploratory or developmental work, meaning it is typically aimed at early-stage ideas, proof-of-concept studies, novel data approaches, pilot projects, and foundational research that can generate preliminary evidence and methods for larger future studies. Clinical trials are optional, so applicants can propose either trial or non-trial research depending on the question and design.

The core purpose of the opportunity is to build knowledge about the ways climate-related exposures and climate-driven disruptions affect the entire cancer control continuum. In practical terms, this can include research on how climate change influences carcinogenic exposures (for example, changes in air pollution patterns, wildfire smoke, extreme heat, flooding and water contamination, occupational exposures, and shifts in infectious agents), as well as how climate-related events and chronic environmental changes affect screening access, diagnostic timeliness, continuity of care, treatment delivery, and outcomes for people living with cancer. It also allows for work on survivorship and supportive care needs under climate stressors, such as heat vulnerability among medically fragile groups, disruptions to medication supply chains, or displacement after extreme weather events that interrupts follow-up care. The emphasis is on connecting climate change to measurable impacts on cancer prevention and control, including differential effects in communities that may face higher exposure burdens, fewer resources to adapt, or greater barriers to care.

A key feature of this NOFO is its broad eligibility. In addition to standard applicant types like state, county, city, and special district governments; public and private institutions of higher education; independent school districts; and federally recognized Tribal governments, the announcement also welcomes applications from Tribal organizations that are not federally recognized, public and Indian housing authorities, nonprofits (both 501(c)(3) and non-501(c)(3)), for-profit organizations (other than small businesses), and small businesses. The NOFO explicitly calls out additional eligible applicants that often reflect underserved or mission-focused institutions and organizations, including Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISI). Faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, and non-U.S. entities (foreign organizations) are also included, signaling an intent to encourage diverse applicants and potentially cross-border or globally relevant climate-cancer research where appropriate.

From an administrative standpoint, the sponsoring agency is NIH/NCI, and the original closing date listed is May 7, 2026. The posting indicates this opportunity was created on November 18, 2024. The public summary text includes a reference to an R01 in the description, but the official title and mechanism presented are R21, which applicants should treat as controlling for scope, budget structure, and project scale. Award ceiling and expected number of awards are not specified in the provided source data, so applicants would need to consult the full NOFO for budget guidance, project period limits, and any special review criteria or program priorities.

Overall, this opportunity is best understood as NCI seeking innovative, early-stage studies that clarify the cancer-related consequences of a changing climate and that can inform interventions, preparedness, and policy across prevention through survivorship. Strong applications will typically make a clear link between specific climate-related hazards or system disruptions and cancer control outcomes, identify populations and settings where impacts are likely to be most important, and propose methods that can produce credible, actionable evidence even at an exploratory R21 scale.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.396.
  • This funding opportunity was created on 2024-11-18.
  • Applicants must submit their applications by 2026-05-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 25 152

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more business programs for Climate Change Organizations

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: DRL Promoting Human Rights and Accountability in the Democratic People’s Republic of Korea (DPRK or North Korea)

Previous opportunity: NOI to Issue Notice of Funding Opportunity DE-FOA-0003495 titled Accelerating CO2 Conversion Technology Development and Deployment – Biological, Catalytic, and Mineralization Pathways.

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 25 152

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 25 152) also looked into and applied for these:

Funding Opportunity
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) Apply for PAR 25 244

Funding Number: PAR 25 244
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) Apply for PAR 25 243

Funding Number: PAR 25 243
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed) Apply for PAR 25 229

Funding Number: PAR 25 229
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed) Apply for PAR 25 228

Funding Number: PAR 25 228
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) Apply for PAR 25 096

Funding Number: PAR 25 096
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) Apply for PAR 25 095

Funding Number: PAR 25 095
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $350,000
NCMRR Early Career Research Award (R03 Clinical Trial Optional) Apply for PAR 25 124

Funding Number: PAR 25 124
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed) Apply for PAR 25 070

Funding Number: PAR 25 070
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional) Apply for PAR 25 069

Funding Number: PAR 25 069
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Advancing Genomic Medicine Research (R21 Clinical Trial Optional) Apply for RFA HG 25 003

Funding Number: RFA HG 25 003
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) Apply for PAR 25 275

Funding Number: PAR 25 275
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Advancing Genomic Medicine Research (R01 Clinical Trial Optional) Apply for RFA HG 25 002

Funding Number: RFA HG 25 002
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Biology of Bladder Cancer (R01 Clinical Trial Optional) Apply for PAR 25 129

Funding Number: PAR 25 129
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Biology of Bladder Cancer (R21 Clinical Trial Optional) Apply for PAR 25 128

Funding Number: PAR 25 128
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $200,000
Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed) Apply for RFA DA 26 034

Funding Number: RFA DA 26 034
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
NCI Pathway to Independence Award (K99/R00 Clinical Trial Not Allowed) Apply for PAR 25 135

Funding Number: PAR 25 135
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Co-infection and Cancer (R21 Clinical Trial Not Allowed) Apply for PAR 25 083

Funding Number: PAR 25 083
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed) Apply for PAR 25 186

Funding Number: PAR 25 186
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional) Apply for PAR 25 235

Funding Number: PAR 25 235
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000
Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed) Apply for PAR 25 107

Funding Number: PAR 25 107
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 25 152", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: